{"name":"ICON Bioscience Inc","slug":"icon-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPc0N0eFRkdHkyUmdQTldQd2xtUU1hZndTdjdGTDVmUHg4ZExPVEpvejBiT1ptRUVPNUdHckRCRUttRkViaS1fb1VNb1NGTzdmdW9WSUdFU1FHa3JWSkd2MjBiaUhUNWQ3dzVtNmFwdDhaaEtSZktSTXRJbGtKVXRjSFM0WlpJdEx1UWdJ?oc=5","date":"2026-02-15","type":"pipeline","source":"Yahoo Finance","summary":"Clinical Research Provider Icon Stock Crashes On Accounting Probe - Yahoo Finance","headline":"Clinical Research Provider Icon Stock Crashes On Accounting Probe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9uSDlYWEpJYXdhQ2drQzhYOHJLd0twQ2Y1WE9rdGlISEk2ZngwWG9ETDNGMHpKQ2Utb0tVcGFNTGVvdEt6VjN1aWE0YWlMaThtd3l2TVdYQ3Z0cEw1RDJFZHlkZnU2WEZUMTdJdGd3ZHFzNUk?oc=5","date":"2025-10-15","type":"trial","source":"Taylor & Francis Online","summary":"HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors: Future Oncology: Vol 21, No 25 - Taylor & Francis Online","headline":"HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors: F","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNeU5UQjJBMHkzTk40cHdEbTF1VkdoNnp3bTBZMlZiQVhVQ29USjNDQXBXckZFdUxfcVhFUHB1cHlyVjFPYnJyeVFUTDRubFRaVVdtbTBKdnZ4ZkNZUjNaRzdZbGROSzcxZGtaazJfejUwR3RGa3ZPQnkwRjFtTEFqUVRLaG8xcjY5S1E?oc=5","date":"2025-09-05","type":"pipeline","source":"Fierce Biotech","summary":"Merck KGaA lands new R&D chief—Chutes & Ladders - Fierce Biotech","headline":"Merck KGaA lands new R&D chief—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQVExBRXhJSXlYYlExYmsxUGlPS1hPalhrZHZuY3U1SkxDSjZ5Y2FnSFprZWlmdGlFaUFncVF2Y2N3SFpmZ1JhNkZvMEJCc1QyRDhtZHp4RlRQdUQ4NFVlclhMXzJsOHJlNG5leUZfbEV3TmVWR3I4a29uMUZxcWJMaDRoTkFyZExpUGZzLXJkRF9NVThzSjRSOUZyakpZTVFWYm9VYmNHTldEeDV5MUM4S1JjS1I?oc=5","date":"2025-08-12","type":"pipeline","source":"bloomberg.com","summary":"Bayer to Pay $1.3 Billion for Kumquat Cancer Drug in Pharma Push - bloomberg.com","headline":"Bayer to Pay $1.3 Billion for Kumquat Cancer Drug in Pharma Push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBEd0FwdzJON1MyZzh3UElEMklVRk03UGNfT3hTT2ljQmFINmRLMC0xSmxFQ1l6OTJ1SzhQUGFHeGNUYm9LYjBOTmduSDVsN0wtSjYtajNLaXpqZnAxaTNGSVV2X1ZvWlFoV05hcHFCYV9xQ0JkUmtrMQ?oc=5","date":"2025-06-17","type":"pipeline","source":"FOREX.com","summary":"Investing in Biotech ETFs - FOREX.com","headline":"Investing in Biotech ETFs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdlRMckRYWHVzUXBFUS1WU2dIUGpXcWZBc2s3YU90MW9tbTdUUFhtVW1aWEMwX0ttamNKZ2wybUZtQU5TWkFkZmRzVW4wZldFRm1sNjhOOTIzX1B4TTdQWjZGLUV1YUotdHV3Z3lHVjRWaWVYZ2JjSWo3NHYxQTAtME13cE5hbXJKLVVrZmh0emlUSkR1VEhXQWkzRmMxUVRz?oc=5","date":"2025-05-23","type":"pipeline","source":"fortune.com","summary":"Top Chinese drugmaker Hengrui soars in Hong Kong trading debut - fortune.com","headline":"Top Chinese drugmaker Hengrui soars in Hong Kong trading debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQTmx1SEJzR2w1dnpoVWFCR2pDWXpQN3JMZnJHQ1g2X2t2ZXZCSTNKdG1rYUh6RWhnYXlNbHozSXVQdVhXVjdDVUFXakFBMVlDU25kSzFmMjRQeklyZ0JuQWFfTUhtZmhfaE5nQXdVM0xRY3EtNU5ZckFSMWlSM3VpZU44UnQySnBlYTliNnhRNEN5eENGTFlZTHVvdDQycXdfSVZieHNhbHRQYnVJWnc?oc=5","date":"2024-08-23","type":"pipeline","source":"PharmTech.com","summary":"Novartis, Versant Create Borealis Biosciences to Develop Kidney Disease Treatments - PharmTech.com","headline":"Novartis, Versant Create Borealis Biosciences to Develop Kidney Disease Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1Mb3h4TFRFVzJ1NlFiMDNwWWlIVTNBdnAzR0gtSk1ZQkJRUnVpaXBHYVJRTF8zNHdEUHE4c1NlOW00SlQxM0NHRjBwRkRtLXNQbFBtakFCZjN4dnFjbkhWYlhuSHNaOGExdmVmOFhLdlVDNkl6alE?oc=5","date":"2024-08-19","type":"pipeline","source":"Precedence Research","summary":"In Vivo CRO Companies | Forecast by 2033 - Precedence Research","headline":"In Vivo CRO Companies | Forecast by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2024-07-15","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPYkc4X2luYk1wbVFCQ2xSVllaZXEtOGJpakN6eDZheEM3Z0FLOHZYbl84MDVQMm5Ebmpmb3Y4RnFCSVBOY2ZhTE5XVFpELUxjOUZza252ekZyYThpdUd2NUFreDdvYzU4c0YwUnlrSHo3dHRaazVnXy1ia2dHUVRSNjFOVHlpbHI0TUI0RHBTeTVBOVpnSjN1RnR1RHlNbDhuX0dMbU9hR1ZUem9YYlJySQ?oc=5","date":"2023-03-10","type":"trial","source":"Contract Pharma","summary":"LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology - Contract Pharma","headline":"LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOGV5b3JKSURHc3dzQzV5bmltT3d2S1JjbmFwVjF6VXVRNkdRajI0cGdYb2dhNjR4VkpxRC05RXhpVzlJRUFUb0RCVjZTU1NmdUprSFR5bjQtME9WZjdyVTN4M0JaYTM4TUtldkh2U3RPbEFIYkllc2d2Z3NJallucTV1MmxXMjl6?oc=5","date":"2022-09-06","type":"pipeline","source":"Pharma Voice","summary":"Entrepreneurs: Lisa Walters-Hoffert - Pharma Voice","headline":"Entrepreneurs: Lisa Walters-Hoffert","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPUDB0YjdTRFQ4cjFDSDRrWUpLanFxeXd1QzVjQV9zdEJVckVrNnNwZWYyRmY3QkFwUDVfRTdiamtKaXVLQ0pqQ1QwR1FsN01CRTRWZHRxRzhQZkdtSzlELVBCc3VQaWhOSWxtMU5OSmJzZG5SNjR0dzViSk1BU2dEZWhMc1FSTDRucTI1U3pqaDhQLVhJYmhDT29fSV9Bdw?oc=5","date":"2018-03-29","type":"deal","source":"MassDevice","summary":"pSivida buys Icon Bioscience and rebrands as EyePoint Pharmaceuticals - MassDevice","headline":"pSivida buys Icon Bioscience and rebrands as EyePoint Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}